Contributor Disclosures for Omphalitis

Role Name Disclosure Details Author  Patrick G Gallagher, MD, Assistant Fellowship Program Director, Associate Professor, Department of Pediatrics, Division of Neonatal-Perinatal Medicine, Yale University and Yale-New Haven Children's Hospital Nothing to disclose Details Coauthor  Samir S Shah, MD, Staff Physician, Departments of Pediatrics and Immunologic and Infectious Diseases, The Children's Hospital of Philadelphia Nothing to disclose Details Medical Editor  Shelley C Springer, MD, MBA, MSc, FAAP, JD LS-3, Assistant Clinical Professor, Department of Pediatrics, University of North Texas Science Center; Clinical Instructor, Department of Pediatrics, University of Wisconsin; Assistant Clinical Professor, Department of Pediatrics, Texas A & M University; Consulting Neonatologist, Pediatrix Medical Group, South Central Region Nothing to disclose Details Pharmacy Editor  Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc Pfizer Inc Avanir Pharma Details Managing Editor  Brian S Carter, MD, FAAP, Professor of Pediatrics, Department of Pediatrics, Division of Neonatology, Vanderbilt University School of Medicine; Co-director, Pediatric Advance Comfort Team, Vanderbilt Children's Hospital Nothing to disclose Details CME Editor  Carol L Wagner, MD, Professor of Pediatrics, Medical University of South Carolina Nothing to disclose Details Chief Editor  Neil N Finer, MD, Professor, Department of Pediatrics, University of California at San Diego School of Medicine; Program Director, Division of Neonatology, University of California San Diego Medical Center Nothing to disclose Details Contributor Disclosure Contributor: Contributor Disclosure: Patrick G Gallagher, Author  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Samir S Shah, Coauthor  The contributor discloses no conflict of interest.  CONTRIBUTOR DISCLOSURE FORM Contributor Name: Shelley C Springer  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Mary L Windle  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Pfizer Inc Stock Investment from broker recommendation   Avanir Pharma Stock Investment from broker recommendation   Off label or investigational use of medication CONTRIBUTOR DISCLOSURE FORM Contributor Name: Brian S Carter  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication None Contributor Disclosure Contributor: Contributor Disclosure: Carol L Wagner, CME Editor  The contributor discloses no conflict of interest.  Contributor Disclosure Contributor: Contributor Disclosure: Neil N Finer, Chief Editor  The contributor discloses no conflict of interest.